National Health Investors, Inc. NHI · NYSE
$65.61 +1.17% (+$0.76)
Summary
83 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 81% a year over the last 3 years.
- Out of every 100 USD of revenue, 38 USD is left as net profit.
- The share price is below the Bulios Fair Price.
- It earns 6.8 USD a year on every 100 USD of invested capital.
What to watch
- Earnings per share swing sharply from year to year.
- For every 100 USD of bills due within a year it has 59 USD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapPrice against the Bulios Fair Price
P/E against its own last 5 years
P/E against the industry (REIT - Healthcare Facilities)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.8 USD for 1 USD of yearly profit. Over the last five years it was 24.8 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 2.6% a year over 5 years. Over the last 3 years it grew by 11% a year. Earnings per share grew by 81% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 35 USD
- Sales and administration 19 USD
- Taxes and other 7.0 USD
- Net profit 38 USD
Net profit, industry median (REIT - Healthcare Facilities) 20 USD
Out of every 100 USD of revenue, 38 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 5.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 5.71%
- Paid out of profit
- 108%
- Raised in a row
- 1 year
You receive $3.70 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 6
- Hold 12
- Sell 1
Today's price within the analysts' price targets
The average target of $79.4 is 21% above today's price. 32% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Real Estate Investment Segment 79%
- Senior Housing Operating Portfolio 21%
By region
The company reports no revenue by region.
Real Estate Investment Segment brings in 79% of revenue. Senior Housing Operating Portfolio grew fastest, by 31% a year.
Segments in detail